Skip to main content

Oyster Point Pharma, Inc.

OYSTDelisted Jan 3, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001720725

Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.

Politicians who traded OYST

No member of Congress has reported a trade in Oyster Point Pharma, Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.